Prediction Market Betting on Drug Trials and Approvals Sparks Concern About Undermining Research

Written by

in

The New York Times – Business:

Prediction markets on Kalshi and Polymarket now let people wager money on drug approvals. Kalshi also plans to allow bets on clinical trial results.

RSS Feed
Author: RSS Feed

This post first appeared in The New York Times – Business. Read the original article.